TSX:OPS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. More Details


Snowflake Analysis

High growth potential and fair value.

Share Price & News

How has Opsens's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: OPS has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-7.9%

OPS

2.9%

CA Medical Equipment

-1.0%

CA Market


1 Year Return

-19.5%

OPS

49.4%

CA Medical Equipment

-4.3%

CA Market

Return vs Industry: OPS underperformed the Canadian Medical Equipment industry which returned 54.1% over the past year.

Return vs Market: OPS underperformed the Canadian Market which returned -4.2% over the past year.


Shareholder returns

OPSIndustryMarket
7 Day-7.9%2.9%-1.0%
30 Day0%0.7%1.3%
90 Day-6.7%4.5%1.9%
1 Year-19.5%-19.5%49.4%49.4%-0.9%-4.3%
3 Year-39.1%-39.1%-48.9%-48.9%6.4%-4.0%
5 Year-23.9%-23.9%-74.3%-74.3%33.3%12.8%

Price Volatility Vs. Market

How volatile is Opsens's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Opsens undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: OPS (CA$0.7) is trading below our estimate of fair value (CA$3.06)

Significantly Below Fair Value: OPS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: OPS is unprofitable, so we can't compare its PE Ratio to the XN Medical Equipment industry average.

PE vs Market: OPS is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate OPS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: OPS is good value based on its PB Ratio (4.3x) compared to the CA Medical Equipment industry average (5.5x).


Next Steps

Future Growth

How is Opsens forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

119.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OPS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.7%).

Earnings vs Market: OPS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: OPS's is expected to become profitable in the next 3 years.

Revenue vs Market: OPS's revenue (25.5% per year) is forecast to grow faster than the Canadian market (5.8% per year).

High Growth Revenue: OPS's revenue (25.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OPS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Opsens performed over the past 5 years?

10.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: OPS is currently unprofitable.

Growing Profit Margin: OPS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: OPS is unprofitable, but has reduced losses over the past 5 years at a rate of 10.7% per year.

Accelerating Growth: Unable to compare OPS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OPS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.2%).


Return on Equity

High ROE: OPS has a negative Return on Equity (-32.76%), as it is currently unprofitable.


Next Steps

Financial Health

How is Opsens's financial position?


Financial Position Analysis

Short Term Liabilities: OPS's short term assets (CA$22.3M) exceed its short term liabilities (CA$5.1M).

Long Term Liabilities: OPS's short term assets (CA$22.3M) exceed its long term liabilities (CA$11.7M).


Debt to Equity History and Analysis

Debt Level: OPS's debt to equity ratio (54.9%) is considered high.

Reducing Debt: OPS's debt to equity ratio has increased from 46.6% to 54.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: OPS has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if OPS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Opsens's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate OPS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OPS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if OPS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OPS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OPS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.1yrs

Average management tenure


CEO

Louis Laflamme

7.75yrs

Tenure

CA$565,814

Compensation

Mr. Louis Laflamme, C.A, C.P.A., has been the Chief Executive Officer and President of Opsens Inc. since January 7, 2013. Mr. Laflamme’s primary mandate is to see to the operational management of the Corpo ...


CEO Compensation Analysis

Compensation vs Market: Louis's total compensation ($USD430.84K) is above average for companies of similar size in the Canadian market ($USD171.43K).

Compensation vs Earnings: Louis's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Alan Milinazzo
Executive Chairman of the Board1.58yrsCA$259.16k0.037%
CA$ 23.4k
Louis Laflamme
President7.75yrsCA$565.81k0.75%
CA$ 476.7k
Robin Villeneuve
CFO & Corporate Secretary3.33yrsCA$235.24k0.028%
CA$ 17.5k
Gaétan Duplain
President of Opsens Solutions & Director14yrsCA$205.63k4.13%
CA$ 2.6m
Pierre Poulin
Corporate Controllerno datano datano data

5.1yrs

Average Tenure

Experienced Management: OPS's management team is seasoned and experienced (5.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Alan Milinazzo
Executive Chairman of the Board1.58yrsCA$259.16k0.037%
CA$ 23.4k
Louis Laflamme
President7.75yrsCA$565.81k0.75%
CA$ 476.7k
Gaétan Duplain
President of Opsens Solutions & Director14yrsCA$205.63k4.13%
CA$ 2.6m
Jean Lavigueur
Independent Director8.75yrsCA$27.34k0.13%
CA$ 84.0k
Denis Sirois
Independent Director14.58yrsCA$23.21k0.44%
CA$ 277.2k
James Mackin
Independent Director4.08yrsCA$20.99k0.049%
CA$ 30.9k
Denis Harrington
Independent Director5.75yrsCA$23.62kno data

7.8yrs

Average Tenure

56yo

Average Age

Experienced Board: OPS's board of directors are considered experienced (7.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Opsens Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Opsens Inc.
  • Ticker: OPS
  • Exchange: TSX
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$63.196m
  • Shares outstanding: 90.28m
  • Website: https://opsens.com

Number of Employees


Location

  • Opsens Inc.
  • 750 Boulevard du Parc-Technologique
  • Québec
  • Quebec
  • G1P 4S3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
OPSTSX (The Toronto Stock Exchange)YesCategory A SharesCACADMay 2006
OPSS.FOTCPK (Pink Sheets LLC)YesCategory A SharesUSUSDMay 2006
5OPDB (Deutsche Boerse AG)YesCategory A SharesDEEURMay 2006

Biography

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in t ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/22 23:54
End of Day Share Price2020/10/21 00:00
Earnings2020/05/31
Annual Earnings2019/08/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.